View drug registration information details.
| Items | Registration information |
|---|
| ID | 349 |
|---|
| No | 349 |
|---|
| Brand Name | GILTERICARE |
|---|
| Ingredients | GILTERITINIB 40 MG |
|---|
| Dosage Form | TABLET |
|---|
| Primary Packaging | BOTTLE |
|---|
| Storage | |
|---|
| Shelf Life | 3 YEARS |
|---|
| Pack Size | BOX OF 28 AND 84'S |
|---|
| Dispensing Category | |
|---|
| ATC Classification | |
|---|
| Pharmaceutical Class | |
|---|
| Indications | USED TO TREAT ADULTS WITH A TYPE OF BLOOD CANCER ACUTE MYELOID LEUKEMIA WHICH HAS A MUTATION IN THE FLT3 GENE |
|---|
| Contraindications | |
|---|
| Side Effects | |
|---|
| Unit Price | |
|---|
| EDL |
NULL |
|---|
| Description | PALE YELLOW COLORED, BREAKLINE ON ONE SIDE AND PLAIN ON THE OTHER |
|---|
| Note | |
|---|
| License Owner | BOTEN ELEMENTO PHARMA FACTORY |
|---|
| Manufacturer | BOTEN ELEMENTO PHARMA FACTORY |
|---|
| Country | LAOS |
|---|
| Import Registration No | |
|---|
| Import Registration Date | |
|---|
| Activity | CERTIFICATE RELEASED |
|---|
| Applied Date | |
|---|
| FDD Registration No | 04 L 1329/25 |
|---|
| FDD Registration Date | 07-APR-2025 |
|---|
| Expiry Date | 06-APR-2030 |
|---|
Back to drug list
|
